EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject:"Brand name drugs"
Narrow search

Narrow search

Year of publication
Subject
All
Pharmaceutical industry 7 Brand-name drugs 6 generic competition 5 Arzneimittel 4 Arzneimittelmarkt 4 Generika 4 Pharmaceutical market 4 Pharmaceuticals 4 Pharmaindustrie 4 Price competition 4 brand name drugs 4 generic drugs 4 Generic drugs 3 Parallel trade 3 Preiswettbewerb 3 brand-name drugs 3 Generic substitution 2 Grauer Markt 2 Grey market 2 Markenartikel 2 Pharmacies 2 Preis 2 Price 2 Schweden 2 Sweden 2 generics 2 pharmaceutical industry 2 prescribing behavior 2 Adjustment 1 Authorized generic drugs 1 Basisgesundheitsversorgung 1 Brand 1 Brand Name Drugs 1 Brand management 1 Brand name drugs 1 Competition 1 Consumer Heterogeneity 1 Consumer Learning 1 Demand Analysis 1 Drug dispensing 1
more ... less ...
Online availability
All
Free 9 Undetermined 3 CC license 1
Type of publication
All
Book / Working Paper 8 Article 7
Type of publication (narrower categories)
All
Article in journal 4 Aufsatz in Zeitschrift 4 Article 2 Working Paper 1
Language
All
English 8 Undetermined 7
Author
All
Granlund, David 8 Rudholm, Niklas 4 Rischatsch, Maurus 3 Trottmann, Maria 3 Bergman, Mats A. 1 Campbell, Eric 1 Ching, Andrew 1 Kaul, Sapna 1 Kirchhoff, Anne 1 Liu, Mengde 1 Morden, Nancy 1 Papanastasiou, Anastasios 1 Vogeli, Christine 1 Yao, Lu 1 Zweifel, Peter 1
more ... less ...
Institution
All
Handelns Utredningsinstitut (HUI Research) 2 Agricultural and Applied Economics Association - AAEA 1 Canadian Centre for Health Economics 1 Institut für Volkswirtschaftslehre, Wirtschaftswissenschaftliche Fakutät 1 Institutionen för Nationalekonomi, Umeå Universitet 1 Volkswirtschaftliche Fakultät, Ludwig-Maximilians-Universität München 1
Published in...
All
HUI Working Papers 2 2014 Annual Meeting, July 27-29, 2014, Minneapolis, Minnesota 1 Advances in Management & Applied Economics 1 Health Economics Review 1 Health economics review 1 International Journal of Health Care Finance and Economics 1 Journal of health economics 1 MPRA Paper 1 Review of industrial organization 1 SOI - Working Papers 1 The European journal of health economics 1 Umeå Economic Studies 1 Working Paper 1 Working Papers / Canadian Centre for Health Economics 1
more ... less ...
Source
All
RePEc 8 ECONIS (ZBW) 4 EconStor 3
Showing 1 - 10 of 15
Cover Image
Strategic behavior and entry deterrence by branded drug firms : the case of authorized generic drugs
Yao, Lu; Liu, Mengde - In: The European journal of health economics 26 (2025) 4, pp. 561-575
Persistent link: https://www.econbiz.de/10015448015
Saved in:
Cover Image
Direct and indirect savings from parallel imports in Sweden
Granlund, David - In: Health Economics Review 12 (2022) 1, pp. 1-14
Background: The aim was: i) to quantify the direct and indirect savings from parallel imports in Sweden during a period when sellers were forbidden from giving discounts to pharmacies, and ii) to study if the efects of competition from parallel imports on list prices became smaller in absolute...
Persistent link: https://www.econbiz.de/10014489924
Saved in:
Cover Image
The price effects of competition from parallel imports and therapeutic alternatives : using dynamic models to estimate the causal effect on the extensive and intensive margins
Granlund, David - In: Review of industrial organization 60 (2022) 1, pp. 63-92
Persistent link: https://www.econbiz.de/10012818171
Saved in:
Cover Image
Direct and indirect savings from parallel imports in Sweden
Granlund, David - In: Health economics review 12 (2022) 1, pp. 1-14
Background: The aim was: i) to quantify the direct and indirect savings from parallel imports in Sweden during a period when sellers were forbidden from giving discounts to pharmacies, and ii) to study if the efects of competition from parallel imports on list prices became smaller in absolute...
Persistent link: https://www.econbiz.de/10013490959
Saved in:
Cover Image
Patent Expiration and Competition: A dynamic limit price model
Papanastasiou, Anastasios - Canadian Centre for Health Economics - 2014
We develop a dynamic model to explore the optimal pricing strategy of a monopolist that faces potential market entry at a given point in time. By engaging in promotional activities, the dominant firm may increase future demand for the product, while by charging below a limit price it can prevent...
Persistent link: https://www.econbiz.de/10010791403
Saved in:
Cover Image
Physician Response to Patient Request for Low Value Care
Kaul, Sapna; Kirchhoff, Anne; Morden, Nancy; Vogeli, … - Agricultural and Applied Economics Association - AAEA - 2014
Persistent link: https://www.econbiz.de/10011068887
Saved in:
Cover Image
Price competition in pharmaceuticals : evidence from 1303 Swedish markets
Granlund, David; Bergman, Mats A. - In: Journal of health economics 61 (2018), pp. 1-12
Persistent link: https://www.econbiz.de/10011999624
Saved in:
Cover Image
Does increased price competition reduce entry of new pharmaceutical products?
Granlund, David; Rudholm, Niklas - In: Advances in Management & Applied Economics 1 (2011) 1, pp. 1-14
In October 2002, a substitution reform was introduced in the Swedish pharmaceuticals market. In this paper, the effects of increased price competition due to the reform on the entry of new pharmaceutical products were studied. The results show that the reform did affect the entry behavior of...
Persistent link: https://www.econbiz.de/10010277132
Saved in:
Cover Image
Physician dispensing and the choice between generic and brand-name drugs: Do margins affect choice?
Rischatsch, Maurus; Trottmann, Maria - 2009
Many politicians blame physician dispensing (PD) to increase health care expenditure and to undermine independence of drug prescription and income leading to a suboptimal medication. Therefore, PD is not allowed in most OECD countries. In Switzerland, PD is allowed in some regions depending on...
Persistent link: https://www.econbiz.de/10010315601
Saved in:
Cover Image
Consumer Learning and Heterogeneity: Dynamics of Demand for Prescription Drugs after Patent Expiration
Ching, Andrew - Volkswirtschaftliche Fakultät, … - 2008
This paper investigates whether aggregate consumer learning together with consumer heterogeneity in price sensitivity could explain why (i) there is a slow diffusion of generic drugs into the market, and (ii) brand-name originators keep increasing their prices over time even after the number of...
Persistent link: https://www.econbiz.de/10005622024
Saved in:
  • 1
  • 2
  • Next
  • Last
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...